{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T03:42:29Z","timestamp":1772336549261,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T00:00:00Z","timestamp":1374192000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s10792-013-9829-0","type":"journal-article","created":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T19:59:03Z","timestamp":1374177543000},"page":"465-476","source":"Crossref","is-referenced-by-count":18,"title":["Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis"],"prefix":"10.1007","volume":"34","author":[{"given":"Wenchang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,19]]},"reference":[{"issue":"3","key":"9829_CR1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140(3):509\u2013516","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"9829_CR2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjo.80.9.844","volume":"80","author":"MS Suttorp-Schulten","year":"1996","unstructured":"Suttorp-Schulten MS, Rothova A (1996) The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 80(9):844\u2013848","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"9829_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10238-004-0034-3","volume":"4","author":"JR Smith","year":"2004","unstructured":"Smith JR (2004) Management of uveitis. Clin Exp Med 4(1):21\u201329","journal-title":"Clin Exp Med"},{"issue":"5","key":"9829_CR4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00006982-200507000-00002","volume":"25","author":"HS Chin","year":"2005","unstructured":"Chin HS, Park TS, Moon YS et al (2005) Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and non-vitrectomized eyes. Retina 25(5):556\u2013560","journal-title":"Retina"},{"issue":"5","key":"9829_CR5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","volume":"109","author":"A Martidis","year":"2002","unstructured":"Martidis A, Duker JS, Greenberg PB et al (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109(5):920\u2013927","journal-title":"Ophthalmology"},{"issue":"2","key":"9829_CR6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.survophthal.2007.12.005","volume":"53","author":"MA Cunningham","year":"2008","unstructured":"Cunningham MA, Edelman JL, Kaushal S (2008) Intravitreal steroids for macular edema: the past, the present, and the future. Surv Ophthalmol 53(2):139\u2013149","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"9829_CR7","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0161-6420(03)00544-X","volume":"110","author":"RF Spaide","year":"2003","unstructured":"Spaide RF, Sorenson J, Maranan L (2003) Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110(8):1517\u20131525","journal-title":"Ophthalmology"},{"issue":"11","key":"9829_CR8","first-page":"1916","volume":"112","author":"H Kok","year":"2005","unstructured":"Kok H, Lau C, Maycock N et al (2005) Outcome of intravitreal triamcinolone in uveitis. Ophthalmology 112(11):1916 e1911\u20131917","journal-title":"Ophthalmology"},{"issue":"2\u20133","key":"9829_CR9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1463-5224.2000.00117.x","volume":"3","author":"BC Gilger","year":"2000","unstructured":"Gilger BC, Malok E, Stewart T et al (2000) Long-term effect on the equine eye of an intravitreal device used for sustained release of cyclosporine A. Vet Ophthalmol 3(2\u20133):105\u2013110","journal-title":"Vet Ophthalmol"},{"issue":"5","key":"9829_CR10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.survophthal.2007.06.004","volume":"52","author":"CM Jermak","year":"2007","unstructured":"Jermak CM, Dellacroce JT, Heffez J et al (2007) Triamcinolone acetonide in ocular therapeutics. Surv Ophthalmol 52(5):503\u2013522","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"9829_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/039463200802100120","volume":"21","author":"E Salvolini","year":"2008","unstructured":"Salvolini E, Neri P, Orciani M, Di Primio R, Giovannini A (2008) Intravitreal micronized triamcinolone versus triamcinolone acetonide: a clinical and morphological comparative study. Int J Immunopathol Pharmacol 21(1):181\u2013188","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"4","key":"9829_CR12","first-page":"317","volume":"6","author":"N Haghjou","year":"2011","unstructured":"Haghjou N, Soheilian M, Abdekhodaie MJ (2011) Sustained release intraocular drug delivery devices for treatment of uveitis. J Ophthalmic Vis Res 6(4):317\u2013329","journal-title":"J Ophthalmic Vis Res"},{"issue":"1","key":"9829_CR13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/10010065","volume":"10","author":"F Delie","year":"2005","unstructured":"Delie F, Blanco-Prieto MJ (2005) Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules 10(1):65\u201380","journal-title":"Molecules"},{"issue":"5","key":"9829_CR14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1461-5347(00)00255-8","volume":"3","author":"GM Barratt","year":"2000","unstructured":"Barratt GM (2000) Therapeutic applications of colloidal drug carriers. Pharm Sci Technol Today 3(5):163\u2013171","journal-title":"Pharm Sci Technol Today"},{"key":"9829_CR15","first-page":"155","volume-title":"Microencapsulation: methods and industrial applications","author":"C Washington","year":"1996","unstructured":"Washington C (1996) Drug release from microparticulate systems. In: Benita S (ed) Microencapsulation: methods and industrial applications. Marcel Dekker, New York, pp 155\u2013181"},{"issue":"5","key":"9829_CR16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12265-010-9210-x","volume":"3","author":"JC Sy","year":"2010","unstructured":"Sy JC, Davis ME (2010) Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers. J Cardiovasc Transl Res 3(5):461\u2013468","journal-title":"J Cardiovasc Transl Res"},{"issue":"6","key":"9829_CR17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1177\/193229680800200611","volume":"2","author":"U Bhardwaj","year":"2008","unstructured":"Bhardwaj U, Papadimitrakopoulos F, Burgess DJ (2008) A review of the development of a vehicle for localized and controlled drug delivery for implantable biosensors. J Diabetes Sci Technol 2(6):1016\u20131029","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"9829_CR18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11095-008-9812-z","volume":"26","author":"S Mansoor","year":"2009","unstructured":"Mansoor S, Kuppermann BD, Kenney MC (2009) Intraocular sustained-release delivery systems for triamcinolone acetonide. Pharm Res 26(4):770\u2013784","journal-title":"Pharm Res"},{"issue":"1","key":"9829_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(01)00200-9","volume":"52","author":"R Herrero-Vanrell","year":"2001","unstructured":"Herrero-Vanrell R, Refojo MF (2001) Biodegradable microspheres for vitreoretinal drug delivery. Adv Drug Deliv Rev 52(1):5\u201316","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"9829_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1076\/ceyr.24.1.39.5427","volume":"24","author":"AI Vallelado","year":"2002","unstructured":"Vallelado AI, Lopez MI, Calonge M et al (2002) Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats. Curr Eye Res 24(1):39\u201345","journal-title":"Curr Eye Res"},{"issue":"2","key":"9829_CR21","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1208\/s12249-010-9445-5","volume":"11","author":"KA Khaled","year":"2010","unstructured":"Khaled KA, Sarhan HA, Ibrahim MA et al (2010) Prednisolone-loaded PLGA microspheres. in vitro characterization and in vivo application in adjuvant-induced arthritis in mice. AAPS Pharm Sci Tech 11(2):859\u2013869","journal-title":"AAPS Pharm Sci Tech"},{"issue":"6","key":"9829_CR22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1006\/exer.2002.2062","volume":"75","author":"T Koga","year":"2002","unstructured":"Koga T, Koshiyama Y, Gotoh T et al (2002) Coinduction of nitric oxide synthase and arginine metabolic enzymes in endotoxin-induced uveitis rats. Exp Eye Res 75(6):659\u2013667","journal-title":"Exp Eye Res"},{"issue":"6","key":"9829_CR23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0021-5155(97)00079-8","volume":"41","author":"RK Hanashiro","year":"1997","unstructured":"Hanashiro RK, Fujino Y, Gugunfu et al (1997) Synthetic lipid A-induced uveitis and endotoxin-induced uveitis\u2014a comparative study. Jpn J Ophthalmol 41(6):355\u2013361","journal-title":"Jpn J Ophthalmol"},{"issue":"5773","key":"9829_CR24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/286611a0","volume":"286","author":"JT Rosenbaum","year":"1980","unstructured":"Rosenbaum JT, McDevitt HO, Guss RB et al (1980) Endotoxin-induced uveitis in rats as a model for human disease. Nature 286(5773):611\u2013613","journal-title":"Nature"},{"issue":"1","key":"9829_CR25","first-page":"88","volume":"32","author":"R Hoekzema","year":"1991","unstructured":"Hoekzema R, Murray PI, van Haren MA et al (1991) Analysis of interleukin-6 in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 32(1):88\u201395","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"9829_CR26","first-page":"442","volume":"36","author":"CK Cheng","year":"1995","unstructured":"Cheng CK, Berger AS, Pearson PA et al (1995) Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis. Invest Ophthalmol Vis Sci 36(2):442\u2013453","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"9829_CR27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.exer.2009.03.012","volume":"89","author":"E Barcia","year":"2009","unstructured":"Barcia E, Herrero-Vanrell R, Diez A et al (2009) Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone. Exp Eye Res 89(2):238\u2013245","journal-title":"Exp Eye Res"},{"key":"9829_CR28","unstructured":"Cardillo JA, Souza-Filho AA, & Oliveira AG (2006) Intravitreal Bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulnes for the treatment of diabetic macular edema. Arch Soc Esp Oftalmol 81(12):675\u2013677, 679\u2013681"},{"issue":"1","key":"9829_CR29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2004.01.011","volume":"96","author":"J Siepmann","year":"2004","unstructured":"Siepmann J, Faisant N, Akiki J et al (2004) Effect of the size of biodegradable microparticles on drug release: experiment and theory. J Control Release 96(1):123\u2013134","journal-title":"J Control Release"},{"issue":"5","key":"9829_CR30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1089\/jop.2011.0215","volume":"28","author":"S Zarei-Ghanavati","year":"2012","unstructured":"Zarei-Ghanavati S, Malaekeh-Nikouei B, Pourmazar R et al (2012) Preparation, characterization, and in vivo evaluation of triamcinolone acetonide microspheres after intravitreal administration. J Ocul Pharmacol Ther 28(5):502\u2013506","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"9829_CR31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.preteyeres.2004.02.003","volume":"23","author":"T Yasukawa","year":"2004","unstructured":"Yasukawa T, Ogura Y, Tabata Y et al (2004) Drug delivery systems for vitreoretinal diseases. Prog Retin Eye Res 23(3):253\u2013281","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"9829_CR32","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1023\/A:1026464124412","volume":"17","author":"R Herrero-Vanrell","year":"2000","unstructured":"Herrero-Vanrell R, Ramirez L, Fernandez-Carballido A et al (2000) Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process. Pharm Res 17(10):1323\u20131328","journal-title":"Pharm Res"},{"issue":"8","key":"9829_CR33","first-page":"921","volume":"25","author":"JM Leeds","year":"1997","unstructured":"Leeds JM, Henry SP, Truong L et al (1997) Pharmacokinetics of a potential human cytomegalovirus therapeutic, a phosphorothioate oligonucleotide, after intravitreal injection in the rabbit. Drug Metab Dispos 25(8):921\u2013926","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"9829_CR34","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1128\/iai.30.3.786-790.1980","volume":"30","author":"EL Howes Jr","year":"1980","unstructured":"Howes EL Jr, Morrison DC (1980) Lipid A dependence of the ocular response to circulating endotoxin in rabbits. Infect Immun 30(3):786\u2013790","journal-title":"Infect Immun"},{"issue":"1","key":"9829_CR35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/IAE.0b013e3181b48fb4","volume":"30","author":"PM Beer","year":"2010","unstructured":"Beer PM, Wong SJ, Schartman JP et al (2010) Infliximab stability after reconstitution, dilution, and storage under refrigeration. Retina 30(1):81\u201384","journal-title":"Retina"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-013-9829-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-013-9829-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-013-9829-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T18:16:23Z","timestamp":1646158583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-013-9829-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,19]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["9829"],"URL":"https:\/\/doi.org\/10.1007\/s10792-013-9829-0","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,19]]}}}